首页> 外国专利> Human P2YLi gene coding for a putative G protein coupled receptor used to develop new drugs and technologies and to evaluate existing drugs

Human P2YLi gene coding for a putative G protein coupled receptor used to develop new drugs and technologies and to evaluate existing drugs

机译:人类P2YLi基因编码一个假定的G蛋白偶联受体,用于开发新药物和新技术以及评估现有药物

摘要

The P2YLi gene, having a 3180 base pair sequence, fully defined in the specification, including 5'- and 3'-untranslated regions, and which overlaps with the gene for acrosomal protein SP32, is new. Independent claims are also included for the following: (1) transcription factors, RNA polymerases, drugs and chemicals that positively or negatively modulate expression of the P2YLi gene; (2) mRNA transcripts of the P2YLi gene, including splice variants and isoforms; (3) cDNA derived from the mRNA or from the intronless P2YLi gene; (4) a protein derived or produced from the mRNA, gene or cDNA; (5) antibodies and antisera raised against one or more epitopes of the proteins or against the protein as a whole; (6) expression systems that express the protein of (4); (7) ligand binding studies and screening assays on native or recombinant receptors or cells or cell membranes containing the protein of (4); (8) transgenic animals and knockout animals which express the protein of (4) at an altered density or not at all; (9) gene therapy methods that concern the protein of (4) or its gene or its mRNA (cDNA) and their development and use; (10) sense and antisense oligonucleotides derived from the P2YLi gene and their use; and (11) diagnosis and treatment of diseases that are directly or indirectly associated with the protein of (4).
机译:新的P2YLi基因具有3180个碱基对序列,在说明书中已完全定义,包括5'和3'非翻译区,并且与顶体蛋白SP32的基因重叠。还包括以下方面的独立权利要求:(1)正或负调节P2YLi基因表达的转录因子,RNA聚合酶,药物和化学物质; (2)P2YLi基因的mRNA转录物,包括剪接变体和同工型; (3)来自mRNA或无内含子的P2YLi基因的cDNA; (4)从mRNA,基因或cDNA衍生或产生的蛋白质; (5)针对蛋白质的一个或多个表位或针对蛋白质整体的抗体和抗血清; (6)表达(4)的蛋白质的表达系统; (7)对含有(4)的蛋白质的天然或重组受体或细胞或细胞膜的配体结合研究和筛选测定; (8)以改变的密度或根本不表达(4)的蛋白质的转基因动物和基因敲除动物; (9)涉及(4)的蛋白质或其基因或其mRNA(cDNA)的基因治疗方法及其开发和应用; (10)源自P2YLi基因的有义和反义寡核苷酸及其用途; (11)与(4)的蛋白质直接或间接相关的疾病的诊断和治疗。

著录项

  • 公开/公告号DE19930285A1

    专利类型

  • 公开/公告日2001-01-04

    原文格式PDF

  • 申请/专利权人 BRUES MICHAEL;BOENISCH HEINZ;

    申请/专利号DE1999130285

  • 发明设计人 BRUES MICHAEL;BOENISCH HEINZ;

    申请日1999-07-02

  • 分类号C12N15/12;C07K16/00;C07K14/005;C12N15/63;

  • 国家 DE

  • 入库时间 2022-08-22 01:10:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号